
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.350 | 0.350 | 0.000 |
Shares | 99.650 | 99.650 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.135 | 20.118 |
Price to Book | 3.286 | 3.962 |
Price to Sales | 2.632 | 2.393 |
Price to Cash Flow | 15.538 | 16.026 |
Dividend Yield | 1.302 | 1.392 |
5 Years Earnings Growth | 14.977 | 11.874 |
Number of long holdings: 57
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 5.19 | 418.64 | -1.32% | |
Eli Lilly | US5324571083 | 4.82 | 884.54 | +2.89% | |
Medincell | FR0004065605 | 4.59 | 14.97 | +0.13% | |
Boston Scientific | US1011371077 | 3.08 | 101.90 | +0.75% | |
Becton Dickinson | US0758871091 | 3.03 | 205.08 | +0.31% | |
AstraZeneca | GB0009895292 | 3.01 | 10,400.0 | -0.42% | |
Novartis | CH0012005267 | 2.77 | 92.54 | +0.59% | |
Merck&Co | US58933Y1055 | 2.65 | 82.74 | +3.63% | |
Thermo Fisher Scientific | US8835561023 | 2.64 | 424.24 | -0.57% | |
Fresenius SE | DE0005785604 | 2.62 | 39.850 | 0.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pluvalca Disruptive Opportunities A | 96.66M | -5.69 | -9.57 | - | ||
Pluvalca Initiatives PME A | 65.63M | 3.70 | -6.96 | 6.58 | ||
Pluvalca France Small Caps A | 64.31M | -0.90 | -4.57 | 3.41 | ||
Pluvalca Allcaps A | 52.38M | 5.92 | 3.63 | 4.92 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review